Intravascular imaging in percutaneous coronary intervention
- PMID: 38401550
- DOI: 10.1016/S0140-6736(23)02686-7
Intravascular imaging in percutaneous coronary intervention
Conflict of interest statement
ZSL reports speakers' fees from AstraZeneca, Biosensors International, and Novartis, unrelated to the topic of this Comment. NR reports speakers' fees from Abbott, unrelated to the topic of this Comment.
Comment on
-
Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.Lancet. 2024 Mar 2;403(10429):824-837. doi: 10.1016/S0140-6736(23)02454-6. Epub 2024 Feb 21. Lancet. 2024. PMID: 38401549
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical